Progress being made toward Mo-99 production at Darlington

Darlington nuclear generating station. Photo: OPG
Ontario Power Generation, its subsidiary Laurentis Energy Partners, and BWXT ITG Canada and its affiliates announced on September 24 that the companies are making “significant progress” toward the production of molybdenum-99 at OPG’s Darlington nuclear power plant. Darlington will become the first commercial operating nuclear reactor to produce the medical radioisotope.
A precursor to technetium-99m, Mo-99 is used in more than 40 million procedures a year to detect cancers and diagnose various medical conditions.



The accounting firm Deloitte on September 21 issued a report on the decarbonization strategies of 22 utilities in the United States.

The International Atomic Energy Agency has just released its latest projections for energy, electricity, and nuclear power trends over the next 30 years. Compared with the previous year, the new projections are largely unchanged.